GlassScriptPhysician profile
Bradley T Moore
NPI 1922047646
$109,951.58
in general payments reported to CMS, 2019-2025
14 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $7,675 · 2021: $12K · 2022: $26K · 2023: $6,867 · 2024: $5,441 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Food and Beverage: $1,641 · Travel and Lodging: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,520.00 |
| Food and Beverage | $1,640.92 |
| Travel and Lodging | $168.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $56,471.15 | 2019-2025 | Linx Reflux Management System |
| Ethicon US, LLC | $32,698.31 | 2019-2025 | Linx Reflux Management System, Linx Reflux Management System, Echelon Flex |
| Intuitive Surgical, INC. | $20,052.84 | 2019-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $140.83 | 2022 | |
| Covidien LP | $130.69 | 2020 | |
| Davol INC. | $115.75 | 2023 | Phasix Mesh |
| Nevro Corp. | $115.61 | 2020 | |
| Baxter Healthcare | $75.04 | 2024 | Perclot |
| Tela Bio, INC. | $40.11 | 2024 | Ovitex 2s |
| Ambu INC. | $30.40 | 2024 | |
| Tolmar, INC. | $25.68 | 2025 | Jatenzo |
| Calyxo, INC. | $20.79 | 2025 | Cvac Aspiration System |
| Dendreon Pharmaceuticals LLC | $20.04 | 2019 | |
| Astellas Pharma US INC | $14.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.